# Leiden Thrombosis Recurrence Risk Prevention

> **NCT06087952** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 608 (estimated)

## Conditions studied

- Venous Thromboembolism
- Venous Thromboses
- Pulmonary Embolism
- Deep Vein Thrombosis

## Interventions

- **OTHER:** Randomised treatment advice (discontinue vs continue after 3 months)
- **DIAGNOSTIC_TEST:** VTE-BLEED score
- **DIAGNOSTIC_TEST:** L-TRRiP score
- **OTHER:** Advise to continue anticoagulant treatment after 3 months
- **OTHER:** Advise to discontinue anticoagulant treatment after 3 months

## Key facts

- **NCT ID:** NCT06087952
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-18
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 608 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087952, "Leiden Thrombosis Recurrence Risk Prevention". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06087952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*